Patents by Inventor Christophe Moinet

Christophe Moinet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spiro compounds and methods for the modulation of chemokine receptor activity
    Patent number: 7288548
    Abstract: Compounds of formula I wherein X, Y, Z, W, R1 and R2 as defined herein, or pharmaceutically acceptable salts, hydrates or solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: October 30, 2007
    Assignee: ViroChem Pharma, Inc.
    Inventors: Laval Chan Chun Kong, Ming-Qiang Zhang, Christophe Moinet, Marc Courchesne, Thumkunta Jagadeeswar Reddy
  • Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use
    Patent number: 7220765
    Abstract: The present invention is drawn to compounds of the formula in racemic and enantiomeric form or all combinations of these forms wherein the various substituents are as defined in the application which compounds have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties.
    Type: Grant
    Filed: July 8, 2003
    Date of Patent: May 22, 2007
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (SCRAS)
    Inventors: Christophe Moinet, Carole Sackur, Christophe Thurieau
  • Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use
    Publication number: 20070043095
    Abstract: The present invention is drawn to compounds of the formula in racemic and enantiomeric form or all combinations of these forms wherein the various substituents are as defined in the application which compounds have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties.
    Type: Application
    Filed: July 8, 2003
    Publication date: February 22, 2007
    Inventors: Christophe Moinet, Carole Sackur, Christophe Thurieau
  • 4-aminopiperidine and their use as a medicine
    Patent number: 7115634
    Abstract: A subject of the present application is new derivatives of 4-aminopiperidines of formula in which R1, R2 and R3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: October 3, 2006
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques
    Inventors: Christophe Thurieau, Jérôme Gonzalez, Christophe Moinet
  • Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
    Publication number: 20060014769
    Abstract: Novel compounds represented by formula (I): wherein R1, R2, R3 and R4 are as defined herein, and pharmaceutically acceptable salts, hydrates and solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.
    Type: Application
    Filed: June 23, 2005
    Publication date: January 19, 2006
    Inventors: Laval Kong, Christophe Moinet, Louis Vaillancourt, Monica Bubenik
  • Derivatives of 4-aminopiperidine and their use a medicament
    Publication number: 20050239796
    Abstract: A subject of the present application is new derivatives of 4-aminopiperidines of formula in which R1, R2 and R3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.
    Type: Application
    Filed: May 4, 2005
    Publication date: October 27, 2005
    Inventors: Christophe Thurieau, Jerome Gonzalez, Christophe Moinet
  • Spiro compounds and methods for the modulation of chemokine receptor activity
    Publication number: 20050075326
    Abstract: Novel compounds represented by formula I: wherein Y, Z, X, W, R1, R2 and R3 are as defined herein, or pharmaceutically acceptable salts, hydrates or solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity and the treatment or prevention of diseases associated therewith.
    Type: Application
    Filed: July 19, 2004
    Publication date: April 7, 2005
    Inventors: Laval Chan Chun Kong, Ming Zhang, Christophe Moinet, Melanie Proulx, Thumkunta Reddy, Marc Courchesne
  • Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
    Publication number: 20050075360
    Abstract: Compounds of formula I wherein R1, R2, R3, R4 and R5 are as defined herein, or pharmaceutically acceptable salts, hydrates or solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.
    Type: Application
    Filed: September 10, 2004
    Publication date: April 7, 2005
    Inventors: Laval Chan Chun Kong, Ming-Qiang Zhang, Christophe Moinet, Marc Courchesne, Thumkunta Reddy, Melanie Proulx
  • Spiro compounds and methods for the modulation of chemokine receptor activity
    Publication number: 20050070563
    Abstract: Compounds of formula I wherein X, Y, Z, W, R1 and R2 as defined herein, or pharmaceutically acceptable salts, hydrates or solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.
    Type: Application
    Filed: September 10, 2004
    Publication date: March 31, 2005
    Inventors: Laval Kong, Ming-Qiang Zhang, Christophe Moinet, Marc Courchesne, Thumkunta Reddy
  • 2-Arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
    Patent number: 6727269
    Abstract: The invention concerns novel 2-arylimino-2,3-dihydrothiazole derivatives of general formula (I), their preparation methods and their use as medicines, in particular for treating pathological conditions or diseases wherein one (or several) somatostatin receptors is/are involved. Said pathological conditions include in particular acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: April 27, 2004
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
    Inventors: Christophe Moinet, Carole Sackur, Christophe Thurieau